Intracameral Vigamox® (Moxifloxacin 0.5%) is Non-Toxic and Effective in Preventing Endophthalmitis in a Rabbit Model

Vigamox® appears to be nontoxic for intracameral injection and effective in preventing experimental endophthalmitis in the rabbit model. Further studies will determine the clinical role of intracameral Vigamox® for surgical prophylaxis and postoperative therapy.